San Diego, CA -- (SBWIRE) -- 11/28/2022 -- The Shareholders Foundation announced that a deadline is coming up on November 28, 2022 in the lawsuit filed for certain investors of Centessa Pharmaceuticals plc (NASDAQ: CNTA)

Investors who purchased shares of Centessa Pharmaceuticals plc (NASDAQ: CNTA) have certain options and there are strict and short deadlines running. Deadline: November 28, 2022. NASDAQ: CNTA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of Centessa Pharmaceuticals plc (NASDAQ: CNTA) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that, the Offering Documents and between May 28, 2021 and June 1, 2022, the Defendants made false and/or misleading statements and/or failed to disclose that lixivaptan was less safe than Defendants had represented, that Defendants overstated lixivaptan's clinical and commercial prospects, that ZF874 was less safe than Defendants had represented; (iv) Defendants overstated ZF874's clinical and commercial prospects while downplaying the drug's safety issues, and that as a result, the Offering Documents and the Company's public statements between May 28, 2021 and June 1, 2022were materially false and/or misleading and failed to state information required to be stated therein.

Those who purchased shares of Centessa Pharmaceuticals plc (NASDAQ: CNTA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.